Ken Griffin Quest Diagnostics Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$137.09 - $137.09 $4.89 Million - $4.89 Million	-35,700 Reduced 29.68%	84,600 $11.6 Million
Q2 2024 Aug 14, 2024	BUY	$125.91 - $144.34 $2.56 Million - $2.93 Million	20,300 Added 20.3%	120,300 $16.5 Million
Q1 2024 May 15, 2024	SELL	$123.78 - $142.11 $1.88 Million - $2.16 Million	-15,200 Reduced 13.19%	100,000 $13.3 Million
Q4 2023 Feb 14, 2024	SELL	$120.62 - $141.12 $2.98 Million - $3.49 Million	-24,700 Reduced 17.66%	115,200 $15.9 Million
Q3 2023 Nov 14, 2023	BUY	$121.86 - $144.92 $7.01 Million - $8.33 Million	57,500 Added 69.78%	139,900 $17 Million
Q2 2023 Aug 14, 2023	SELL	$130.56 - $146.84 $5.85 Million - $6.58 Million	-44,800 Reduced 35.22%	82,400 $11.6 Million
Q1 2023 May 15, 2023	SELL	$131.53 - $155.76 $5.93 Million - $7.02 Million	-45,100 Reduced 26.18%	127,200 $18 Million
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $4.56 Million - $5.82 Million	37,000 Added 27.35%	172,300 $26.9 Million
Q3 2022 Nov 14, 2022	SELL	$121.77 - $141.1 $5.39 Million - $6.25 Million	-44,300 Reduced 24.67%	135,300 $16.6 Million

923

95M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.